Seppic, a subsidiary of Air Liquide Healthcare, inaugurated a new production unit at its Lons facility near Pau, France, on 27 October 2026, according to a press statement by the company. The investment marks a key milestone for the speciality ingredients producer in response to growing global demand for purified natural active ingredients.
The new 1,400 m² building at Seppic’s eight-hectare Lons site, which employs more than 50 people, will triple production capacity for Ceramosides, a key range serving both the nutrition and beauty markets.
Growing global demand
Ceramosides ingredients are wheat extracts rich in phytoceramides, available for topical and oral use, with clinically proven benefits for anti-ageing, skin hydration and hair loss reduction, the company states.
Ceramides are widely recognised as a key ingredient in both cosmetics and nutrition. The hashtag #ceramides has attracted…










